L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus
about
Hepatitis C virus proteinsInitiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type IEmerging concepts in immunity to hepatitis C virus infection.Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and InfectionCharacterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter VirusesEvaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine VehicleExpression of DC-SIGN and DC-SIGNR on Human Sinusoidal EndotheliumHepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and NeutralizationDissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 bindingAnalysis of a conserved RGE/RGD motif in HCV E2 in mediating entryHepatitis C Virus entry: the early steps in the viral replication cycleMutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entryMouse-Specific Residues of Claudin-1 Limit Hepatitis C Virus Genotype 2a Infection in a Human Hepatocyte Cell LineThe impact of hepatitis C virus entry on viral tropismHuman hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivoFusogenic properties of the ectodomains of hepatitis C virus envelope proteins.Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2.Influence of dendritic cells on viral pathogenicityAdaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.Mutations within a conserved region of the hepatitis C virus E2 glycoprotein that influence virus-receptor interactions and sensitivity to neutralizing antibodies.Hepatitis C virus entry: molecular mechanisms and targets for antiviral therapy.Human cytomegalovirus entry into dendritic cells occurs via a macropinocytosis-like pathway in a pH-independent and cholesterol-dependent manner.Barriers of hepatitis C virus interspecies transmissionA look behind closed doors: interaction of persistent viruses with dendritic cells.Liver immunology.N-linked glycosylation facilitates sialic acid-independent attachment and entry of influenza A viruses into cells expressing DC-SIGN or L-SIGNLectin switching during dengue virus infectionNew Methods in Tissue Engineering: Improved Models for Viral InfectionMolecular and contextual markers of hepatitis C virus and drug abuse.Human Blood-Circulating Basophils Capture HIV-1 and Mediate Viral trans-Infection of CD4+ T Cells.Respiratory syncytial virus and innate immunity: a complex interplay of exploitation and subversion.Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replicationGenome-wide association analysis identifies genetic variations in subjects with myalgic encephalomyelitis/chronic fatigue syndrome.ERK signaling is triggered by hepatitis C virus E2 protein through DC-SIGNHepatitis C virus entry.Recent advances in our understanding of receptor binding, viral fusion and cell entry of hepatitis C virus: new targets for the design of antiviral agents.Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
P2860
Q24563969-585B414B-1EFE-41FB-B6DC-9CBFDC85B0BFQ24676039-9E3BA4A1-4B49-4163-BF2A-7488665B8720Q27002588-94D2CCBC-3765-4BDF-A632-D9284CF7094FQ27010312-03EDADB1-3369-459D-BE85-C57174CA1A05Q27469844-7639A4C9-660B-4D32-B7A1-5DAB7C5494DFQ27472768-3C76E3F8-14A3-48BC-938F-ECEAD2A4AFBBQ27472821-19A3626C-633D-4EAB-8B63-F26A0D70E16EQ27473226-9632F8EF-6FED-4D9B-BE57-C8E839C14EA6Q27473287-F674D3F2-A804-4DC0-9F98-64FBC7F51472Q27477777-BDC2BAD3-A115-439B-97B5-DA2F32445DEAQ27481012-22438FAA-5004-425C-98A8-E6AB62D65739Q27485638-A503E449-EF05-4380-A161-ED54C9E5E040Q27487872-D52DA1D1-51A8-4D8F-A29B-F22D4C297861Q27489242-09A35F2D-0037-495E-808B-BC404BCC0D4EQ27489898-56A9606D-0661-4947-BE47-2E2FA93AEDEDQ27490526-AE546AF4-51F0-44D9-8296-EC6B895CDC32Q27693297-66BC47E1-A7D1-4D23-8D9C-5862D09422EBQ28265835-64D123D1-8B2E-4788-9BC9-C91D9526DD6DQ30360986-41B1018D-9852-44B4-A789-67120066E527Q30425776-E525BA49-FB93-400F-A514-570698F7871DQ33489629-B3E8AFDF-D847-48CB-A838-997FF4C84CD7Q33628805-3BFC0651-7614-4D8E-86F6-685687D82806Q33877381-881693F7-3660-4420-BE1A-1DDD1B53F3F2Q34016463-B6D9021F-FECA-4239-90C8-93AC9B92899DQ34230355-8181DE69-367C-4942-B1CB-B6548BE91CA1Q34315915-24F9EC49-E281-4DF1-B946-4BA803D354BEQ34335916-B369B62E-A7C7-409A-ABF8-9E76C10A3368Q34359990-083106F3-0079-404D-8F2A-35DE982E4429Q34742902-D93DA6A5-3E5C-4A2F-88A5-F789490F74C8Q35000894-83603F8B-ACD6-4298-A095-76C889FABB0AQ35431256-2735060E-0CF5-470E-A872-A708DCF6E953Q35660841-46BD7644-77F4-4787-B128-9BF21B7DA966Q35861208-6A41775B-E878-449E-9AAE-67AE43199663Q36530226-7C83C1BB-C67D-44A9-9D23-C9C3D2176BF5Q36612971-1A6A3523-6E90-470A-8FE6-42C3719DB984Q36915419-6720FDAE-0921-43DF-8306-A092E6893900Q36927297-CF3DDDA7-BF7F-4EFE-AC1A-FD53873BAC2DQ36946317-36B2E4E9-83A2-4B7A-8E31-793A56A93636Q36956517-AA0A29A6-0645-4498-A5A9-D286434B642CQ37247077-3175BC46-0FC8-48D5-9DE9-5CF173AE51F9
P2860
L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
L-SIGN (CD209L) and DC-SIGN (C ...... ver cells by hepatitis C virus
@en
L-SIGN
@nl
type
label
L-SIGN (CD209L) and DC-SIGN (C ...... ver cells by hepatitis C virus
@en
L-SIGN
@nl
prefLabel
L-SIGN (CD209L) and DC-SIGN (C ...... ver cells by hepatitis C virus
@en
L-SIGN
@nl
P2093
P2860
P356
P1476
L-SIGN (CD209L) and DC-SIGN (C ...... ver cells by hepatitis C virus
@en
P2093
Catherine Manix
Emmanuel G Cormier
Fotini Tsamis
Jason P Gardner
Lise Boussemart
Robert J Durso
Tatjana Dragic
William C Olson
P2860
P304
14067-14072
P356
10.1073/PNAS.0405695101
P407
P577
2004-09-15T00:00:00Z